Literature DB >> 10235513

Estimated HIV risk among Hispanics in a national sample of drug users.

I D Montoya1, D C Bell, A J Richard, J W Carlson, R A Trevino.   

Abstract

OBJECTIVE: To estimate and compare the HIV risks among three Hispanic subpopulations.
METHODS: Chronic drug users participating in a nationwide intervention study on drug use were interviewed with regard to drug use and sexual behavior. HIV risk was estimated using information about individuals' HIV-relevant behaviors, the social context (i.e., city) in which such behaviors occur, and published estimates of HIV transmission for various risk behaviors. Multiple linear regression analysis was used to investigate differences in estimated HIV risk between Puerto Rican, Mexican-American, and Mexican drug users, accounting for sociodemographic factors, sexual preference, and geographic region.
RESULTS: Puerto Ricans had significantly greater estimated overall HIV risk, estimated injection risk, and in general, significantly greater estimated sexual risk than Mexican Americans and Mexicans. No significant differences were found in any estimated risk between Mexican Americans and Mexicans in this sample. No significant differences were found among any of the subgroups for estimated risk from having anal sex while using a condom, or from having receptive anal sex without using a condom.
CONCLUSIONS: These findings suggest that Puerto Ricans who use drugs experience a higher risk of HIV infection than other Hispanic drug users. Research is needed to identify which economic, social, and cultural components account for this increased risk.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10235513     DOI: 10.1097/00126334-199905010-00006

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  7 in total

1.  Migration and HIV risk behaviors: Puerto Rican drug injectors in New York City and Puerto Rico.

Authors:  Sherry Deren; Sung-Yeon Kang; Hector M Colón; Jonny F Andia; Rafaela R Robles; Denise Oliver-Velez; Ann Finlinson
Journal:  Am J Public Health       Date:  2003-05       Impact factor: 9.308

2.  Estimates of the population prevalence of injection drug users among hispanic residents of large US metropolitan areas.

Authors:  Enrique R Pouget; Samuel R Friedman; Charles M Cleland; Barbara Tempalski; Hannah L F Cooper
Journal:  J Urban Health       Date:  2012-06       Impact factor: 3.671

3.  A comparative study of mortality among Puerto Rican injection drug users in East Harlem, New York, and Bayamon, Puerto Rico.

Authors:  Hector Manuel Colon; Sherry Deren; Rafaela Rivera Robles; Sung-Yeon Kang; Myrna Cabassa; Hardeo Sahai
Journal:  J Urban Health       Date:  2006-11       Impact factor: 3.671

4.  Prevalence and correlates of hepatitis C virus infection among street-recruited injection drug users in San Juan, Puerto Rico.

Authors:  Juan C Reyes; Héctor M Colón; Rafael R Robles; Eddy Rios; Tomás D Matos; Juan Negrón; Carmen Amalia Marrero; José M Calderón; Elizabeth Shepard
Journal:  J Urban Health       Date:  2006-11       Impact factor: 3.671

5.  Factors mediating and moderating the relationship between gender and utilization of health care among Puerto Rican drug users in New York.

Authors:  Sung-Yeon Kang; Sherry Deren
Journal:  Drug Alcohol Depend       Date:  2009-04-14       Impact factor: 4.492

6.  Racialized risk environments in a large sample of people who inject drugs in the United States.

Authors:  Hannah L F Cooper; Sabriya Linton; Mary E Kelley; Zev Ross; Mary E Wolfe; Yen-Tyng Chen; Maria Zlotorzynska; Josalin Hunter-Jones; Samuel R Friedman; Don Des Jarlais; Salaam Semaan; Barbara Tempalski; Elizabeth DiNenno; Dita Broz; Cyprian Wejnert; Gabriela Paz-Bailey
Journal:  Int J Drug Policy       Date:  2015-08-08

7.  HIV risks and seroprevalence among Mexican American injection drug users in California.

Authors:  Alexis N Martinez; Ricky N Bluthenthal; Neil M Flynn; Rachel L Anderson; Alex H Kral
Journal:  AIDS Behav       Date:  2011-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.